Literature DB >> 12594836

Dok protein family members are involved in signaling mediated by the type 1 Fcepsilon receptor.

Jakub Abramson1, Guido Rozenblum, Israel Pecht.   

Abstract

Aggregation of type 1 Fcepsilon receptors (FcepsilonRI) on mast cells activates a biochemical cascade that culminates in secretion of inflammatory mediators, as well as in changes of cell morphology and adhesion properties. Some of the intracellular components involved in the early coupling events are still unidentified. Here we show that two adaptor proteins, downstream of tyrosine kinases (Dok)-1 and Dok-2, are involved in the FcepsilonRI coupling cascade in the rat mucosal-type mast cells of the RBL-2H3 line. Dok-1 is found to be constitutively associated with the FcepsilonRI, even in untreated cells, and this interaction is not affected by this receptor's aggregation. Both Dok forms undergo a fast and relatively long-term tyrosyl-phosphorylation. This modification of Dok-1 increases its association with RasGAP, suggesting that it is modulating Ras activity. Indeed, we further found that FcepsilonRI-mediated Ras/Raf1/Erk signaling as well as the de novo synthesis of TNF-alpha are markedly reduced in cells overexpressing Dok-1. Moreover, FcepsilonRI clustering causes both Dok-1 and Dok-2 to become docking sites for other signaling molecules including Nck, CrkL and Cas. The latter proteins have been implicated particularly in regulation of the actin-cytoskeletal reorganization. Hence Dok-1/Dok-2 may also be involved in the FcepsilonRI-stimulated processes of cytoskeleton rearrangement required for cell adhesion, membrane ruffling and exocytosis.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12594836     DOI: 10.1002/immu.200390011

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  8 in total

1.  Downstream of tyrosine kinase 1 and 2 play opposing roles in CD200 receptor signaling.

Authors:  Robin Mihrshahi; Marion H Brown
Journal:  J Immunol       Date:  2010-11-15       Impact factor: 5.422

2.  Dok-2 adaptor protein regulates the shear-dependent adhesive function of platelet integrin αIIbβ3 in mice.

Authors:  Sascha C Hughan; Christopher M Spring; Simone M Schoenwaelder; Sharelle Sturgeon; Imala Alwis; Yuping Yuan; James D McFadyen; Erik Westein; Duncan Goddard; Akiko Ono; Yuji Yamanashi; Warwick S Nesbitt; Shaun P Jackson
Journal:  J Biol Chem       Date:  2014-01-02       Impact factor: 5.157

3.  Notch ligand Delta-like1 enhances degranulation and cytokine production through a novel Notch/Dok-1/MAPKs pathway in vitro.

Authors:  Songsong Jiang; Yifan Da; Shiwen Han; Yahong He; Huilian Che
Journal:  Immunol Res       Date:  2018-02       Impact factor: 2.829

4.  Phospholipase C-β3 regulates FcɛRI-mediated mast cell activation by recruiting the protein phosphatase SHP-1.

Authors:  Wenbin Xiao; Jun-Ichi Kashiwakura; Hong Hong; Hiroki Yasudo; Tomoaki Ando; Mari Maeda-Yamamoto; Dianqing Wu; Yuko Kawakami; Toshiaki Kawakami
Journal:  Immunity       Date:  2011-06-16       Impact factor: 31.745

5.  Selective inhibition of the Fc epsilon RI-induced de novo synthesis of mediators by an inhibitory receptor.

Authors:  Jakub Abramson; Arieh Licht; Israel Pecht
Journal:  EMBO J       Date:  2006-01-12       Impact factor: 11.598

6.  Functional analysis of Lyn kinase A and B isoforms reveals redundant and distinct roles in Fc epsilon RI-dependent mast cell activation.

Authors:  Damiana Alvarez-Errico; Yumi Yamashita; Ryo Suzuki; Sandra Odom; Yasuko Furumoto; Toshiyuki Yamashita; Juan Rivera
Journal:  J Immunol       Date:  2010-03-22       Impact factor: 5.422

Review 7.  Adapters in the organization of mast cell signaling.

Authors:  Damiana Alvarez-Errico; Eva Lessmann; Juan Rivera
Journal:  Immunol Rev       Date:  2009-11       Impact factor: 12.988

8.  T cell receptor for antigen induces linker for activation of T cell-dependent activation of a negative signaling complex involving Dok-2, SHIP-1, and Grb-2.

Authors:  Shen Dong; Béatrice Corre; Eliane Foulon; Evelyne Dufour; André Veillette; Oreste Acuto; Frédérique Michel
Journal:  J Exp Med       Date:  2006-10-16       Impact factor: 14.307

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.